The Claim
Neuropeptide Y is an independent predictor of ventricular premature beats occurrence after adjusting for age, gender, and autonomic markers, with an odds ratio of 1.008 per 1 ng/L increase in serum NPY (95% CI: 1.001–1.015, p=0.010).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher levels of neuropeptide Y in the blood are associated with a small but statistically significant increase in the occurrence of ventricular premature beats, even after accounting for age, gender, and nervous system activity.
See the scientific wording
Neuropeptide Y is an independent predictor of ventricular premature beats (VES) occurrence after adjusting for age, gender, and autonomic markers, with an odds ratio of 1.008 per 1 ng/L increase in serum NPY (95% CI: 1.001–1.015, p=0.010), indicating that even small increases in NPY are associated with higher VES risk.
Higher levels of Neuropeptide Y in the blood increase signals from the sympathetic nervous system to the heart while reducing signals from the parasympathetic nervous system. This imbalance makes heart muscle cells more excitable and delays their recovery after beating, which causes abnormal extra beats to start in the lower chambers of the heart.
What the research says
1 studyStudy: The Association of Neuropeptide Y with the Presence and Frequency of Ventricular Premature Beats
This study found that people with more of a blood chemical called NPY are more likely to have extra heartbeats, even after accounting for age, sex, and nervous system activity — so yes, even small increases in NPY are linked to more extra heartbeats.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.